Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia

L. Bockor, G. Bortolussi, S. Vodret, A. Iaconcig, J. Jašprová, J. Zelenka, L. Vitek, C. Tiribelli, AF. Muro,

. 2017 ; 26 (1) : 145-157.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031186

Moderate neonatal jaundice is the most common clinical condition during newborn life. However, a combination of factors may result in acute hyperbilirubinemia, placing infants at risk of developing bilirubin encephalopathy and death by kernicterus. While most risk factors are known, the mechanisms acting to reduce susceptibility to bilirubin neurotoxicity remain unclear. The presence of modifier genes modulating the risk of developing bilirubin-induced brain damage is increasingly being recognised. The Abcb1 and Abcc1 members of the ABC family of transporters have been suggested to have an active role in exporting unconjugated bilirubin from the central nervous system into plasma. However, their role in reducing the risk of developing neurological damage and death during neonatal development is still unknown.To this end, we mated Abcb1a/b-/- and Abcc1-/- strains with Ugt1-/- mice, which develop severe neonatal hyperbilirubinemia. While about 60% of Ugt1-/- mice survived after temporary phototherapy, all Abcb1a/b-/-/Ugt1-/- mice died before postnatal day 21, showing higher cerebellar levels of unconjugated bilirubin. Interestingly, Abcc1 role appeared to be less important.In the cerebellum of Ugt1-/- mice, hyperbilirubinemia induced the expression of Car and Pxr nuclear receptors, known regulators of genes involved in the genotoxic response.We demonstrated a critical role of Abcb1 in protecting the cerebellum from bilirubin toxicity during neonatal development, the most clinically relevant phase for human babies, providing further understanding of the mechanisms regulating bilirubin neurotoxicity in vivo. Pharmacological treatments aimed to increase Abcb1 and Abcc1 expression, could represent a therapeutic option to reduce the risk of bilirubin neurotoxicity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031186
003      
CZ-PrNML
005      
20171030131243.0
007      
ta
008      
171025s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/hmg/ddw375 $2 doi
035    __
$a (PubMed)28025333
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bockor, Luka $u International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
245    10
$a Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia / $c L. Bockor, G. Bortolussi, S. Vodret, A. Iaconcig, J. Jašprová, J. Zelenka, L. Vitek, C. Tiribelli, AF. Muro,
520    9_
$a Moderate neonatal jaundice is the most common clinical condition during newborn life. However, a combination of factors may result in acute hyperbilirubinemia, placing infants at risk of developing bilirubin encephalopathy and death by kernicterus. While most risk factors are known, the mechanisms acting to reduce susceptibility to bilirubin neurotoxicity remain unclear. The presence of modifier genes modulating the risk of developing bilirubin-induced brain damage is increasingly being recognised. The Abcb1 and Abcc1 members of the ABC family of transporters have been suggested to have an active role in exporting unconjugated bilirubin from the central nervous system into plasma. However, their role in reducing the risk of developing neurological damage and death during neonatal development is still unknown.To this end, we mated Abcb1a/b-/- and Abcc1-/- strains with Ugt1-/- mice, which develop severe neonatal hyperbilirubinemia. While about 60% of Ugt1-/- mice survived after temporary phototherapy, all Abcb1a/b-/-/Ugt1-/- mice died before postnatal day 21, showing higher cerebellar levels of unconjugated bilirubin. Interestingly, Abcc1 role appeared to be less important.In the cerebellum of Ugt1-/- mice, hyperbilirubinemia induced the expression of Car and Pxr nuclear receptors, known regulators of genes involved in the genotoxic response.We demonstrated a critical role of Abcb1 in protecting the cerebellum from bilirubin toxicity during neonatal development, the most clinically relevant phase for human babies, providing further understanding of the mechanisms regulating bilirubin neurotoxicity in vivo. Pharmacological treatments aimed to increase Abcb1 and Abcc1 expression, could represent a therapeutic option to reduce the risk of bilirubin neurotoxicity.
650    _2
$a zvířata $7 D000818
650    _2
$a novorozená zvířata $7 D000831
650    _2
$a bilirubin $x toxicita $7 D001663
650    _2
$a viabilita buněk $7 D002470
650    _2
$a mozeček $x účinky léků $x patologie $7 D002531
650    12
$a modely nemocí na zvířatech $7 D004195
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glukuronosyltransferasa $x fyziologie $7 D014453
650    _2
$a lidé $7 D006801
650    _2
$a novorozenecká hyperbilirubinemie $x komplikace $x metabolismus $x patologie $7 D051556
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši knockoutované $7 D018345
650    _2
$a proteiny spojené s mnohočetnou rezistencí k lékům $x genetika $x metabolismus $7 D027425
650    _2
$a neurotoxické syndromy $x etiologie $x metabolismus $x patologie $7 D020258
650    _2
$a P-glykoprotein $x genetika $x metabolismus $7 D020168
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bortolussi, Giulia $u International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
700    1_
$a Vodret, Simone $u International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
700    1_
$a Iaconcig, Alessandra $u International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
700    1_
$a Jašprová, Jana $u Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Zelenka, Jaroslav $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technicka 3, 166 28 Prague, Czech Republic.
700    1_
$a Vitek, Libor $u Institute of Medical Biochemistry and Laboratory Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic. Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Tiribelli, Claudio $u Centro Studi Fegato, Fondazione Italiana Fegato, AREA Science Park, Campus Basovizza Trieste, Italy and.
700    1_
$a Muro, Andrés F $u International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
773    0_
$w MED00002077 $t Human molecular genetics $x 1460-2083 $g Roč. 26, č. 1 (2017), s. 145-157
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28025333 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171030131332 $b ABA008
999    __
$a ok $b bmc $g 1254779 $s 992213
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 26 $c 1 $d 145-157 $i 1460-2083 $m Human molecular genetics $n Hum Mol Genet $x MED00002077
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace